167 related articles for article (PubMed ID: 27131597)
1. Transformable DNA nanocarriers for plasma membrane targeted delivery of cytokine.
Sun W; Ji W; Hu Q; Yu J; Wang C; Qian C; Hochu G; Gu Z
Biomaterials; 2016 Jul; 96():1-10. PubMed ID: 27131597
[TBL] [Abstract][Full Text] [Related]
2. Engineering of Neutrophil Membrane Camouflaging Nanoparticles Realizes Targeted Drug Delivery for Amplified Antitumor Therapy.
Wang J; Gu X; Ouyang Y; Chu L; Xu M; Wang K; Tong X
Int J Nanomedicine; 2021; 16():1175-1187. PubMed ID: 33623381
[TBL] [Abstract][Full Text] [Related]
3. Immuno-LipoTRAIL: Targeted delivery of TRAIL-functionalized liposomal nanoparticles.
Seifert O; Pollak N; Nusser A; Steiniger F; Rüger R; Pfizenmaier K; Kontermann RE
Bioconjug Chem; 2014 May; 25(5):879-87. PubMed ID: 24766622
[TBL] [Abstract][Full Text] [Related]
4. Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles.
Lee AL; Dhillon SH; Wang Y; Pervaiz S; Fan W; Yang YY
Mol Biosyst; 2011 May; 7(5):1512-22. PubMed ID: 21350763
[TBL] [Abstract][Full Text] [Related]
5. Self-assembled amphiphilic DNA-cholesterol/DNA-peptide hybrid duplexes with liposome-like structure for doxorubicin delivery.
Choi KM; Kwon IC; Ahn HJ
Biomaterials; 2013 May; 34(16):4183-4190. PubMed ID: 23480955
[TBL] [Abstract][Full Text] [Related]
6. Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy.
Wu X; Wang S; Li M; Wang A; Zhou Y; Li P; Wang Y
Nanoscale; 2017 Sep; 9(37):13879-13904. PubMed ID: 28914952
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer.
Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi YW; Choi HG; Park ES; Lee KC; Youn YS
Pharm Res; 2016 Mar; 33(3):615-26. PubMed ID: 26526555
[TBL] [Abstract][Full Text] [Related]
8. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer.
Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS
Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types.
Bae S; Ma K; Kim TH; Lee ES; Oh KT; Park ES; Lee KC; Youn YS
Biomaterials; 2012 Feb; 33(5):1536-46. PubMed ID: 22118776
[TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin immuno hybrid nanoparticles for active targeting: an approach for enhanced apoptotic activity and drug delivery to colorectal tumors.
Tummala S; Gowthamarajan K; Satish Kumar MN; Wadhwani A
Drug Deliv; 2016 Jun; 23(5):1773-87. PubMed ID: 26377238
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy.
Guimarães PPG; Gaglione S; Sewastianik T; Carrasco RD; Langer R; Mitchell MJ
ACS Nano; 2018 Feb; 12(2):912-931. PubMed ID: 29378114
[TBL] [Abstract][Full Text] [Related]
12. Layer by layer assembly of albumin nanoparticles with selective recognition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Cui W; Wang A; Zhao J; Yang X; Cai P; Li J
J Colloid Interface Sci; 2016 Mar; 465():11-7. PubMed ID: 26641559
[TBL] [Abstract][Full Text] [Related]
13. Tumor Microenvironment-Mediated Construction and Deconstruction of Extracellular Drug-Delivery Depots.
Hu Q; Sun W; Lu Y; Bomba HN; Ye Y; Jiang T; Isaacson AJ; Gu Z
Nano Lett; 2016 Feb; 16(2):1118-26. PubMed ID: 26785163
[TBL] [Abstract][Full Text] [Related]
14. Novel Water-Borne Polyurethane Nanomicelles for Cancer Chemotherapy: Higher Efficiency of Folate Receptors Than TRAIL Receptors in a Cancerous Balb/C Mouse Model.
Ajorlou E; Khosroushahi AY; Yeganeh H
Pharm Res; 2016 Jun; 33(6):1426-39. PubMed ID: 26908046
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle hardness controls the internalization pathway for drug delivery.
Li Y; Zhang X; Cao D
Nanoscale; 2015 Feb; 7(6):2758-69. PubMed ID: 25585060
[TBL] [Abstract][Full Text] [Related]
16. Cytosolic co-delivery of miRNA-34a and docetaxel with core-shell nanocarriers via caveolae-mediated pathway for the treatment of metastatic breast cancer.
Zhang L; Yang X; Lv Y; Xin X; Qin C; Han X; Yang L; He W; Yin L
Sci Rep; 2017 Apr; 7():46186. PubMed ID: 28383524
[TBL] [Abstract][Full Text] [Related]
17. Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery.
Mandal BB; Kundu SC
Nanotechnology; 2009 Sep; 20(35):355101. PubMed ID: 19671963
[TBL] [Abstract][Full Text] [Related]
18. Smart IR780 Theranostic Nanocarrier for Tumor-Specific Therapy: Hyperthermia-Mediated Bubble-Generating and Folate-Targeted Liposomes.
Guo F; Yu M; Wang J; Tan F; Li N
ACS Appl Mater Interfaces; 2015 Sep; 7(37):20556-67. PubMed ID: 26322900
[TBL] [Abstract][Full Text] [Related]
19. Facile Layer-by-Layer Self-Assembly toward Enantiomeric Poly(lactide) Stereocomplex Coated Magnetite Nanocarrier for Highly Tunable Drug Deliveries.
Li Z; Yuan D; Jin G; Tan BH; He C
ACS Appl Mater Interfaces; 2016 Jan; 8(3):1842-53. PubMed ID: 26717323
[TBL] [Abstract][Full Text] [Related]
20. Cytokines from the tumor microenvironment modulate sirtinol cytotoxicity in A549 lung carcinoma cells.
Pal S; Shankar BS; Sainis KB
Cytokine; 2013 Oct; 64(1):196-207. PubMed ID: 23972545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
